See also Part 1 and Part 2 Case 1 You review a man in the Emergency Department with scrotal pain and sepsis. His clinical examination findings are shown. What does this image show? Who was this condition named after? What...
Case 1 What radiological test is this and what does it show? What is the typical radio-nucleotide used for this study, what is its half-life and how is it excreted? Approximately how long does this study take to perform? What...
In January 2016, the UK National Screening Committee once again recommended against a systematic population screening programme for prostate cancer due to the, as yet, insufficient evidence that the benefits of screening would outweigh the harm to the population as...
1 May 2015
| Taimur Shah, Maneesh Ghei, Hashim U Ahmed (Prof), Manit Arya
|
URO - Urologic Oncology
Introduction Cryotherapy was first described by Dr James Arnott in 1850 where he used crushed ice and salt to get temperatures as low as -24oC, in the treatment of cervical and breast tumours [1]. The literature on prostatic cryotherapy dates...
1 July 2021
| Lucy Brooks, Jonathan Charles Goddard
|
URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk/museum). For July/August 2021, I’m joined by Lucy Brooks, Urology Trainee, who was keen...
This article is the second in a three-part series which follows directly on from the first part which concentrated on the rationale for going on a fellowship, as well as some of the administrative hurdles you might face in planning...
Pelviva® has teamed up with talkhealth, Bladder & Bowel UK, ERIC, The Urology Foundation and Wellbeing for Women to present an Online Clinic on Bladder Issues Online clinic on bladder issues 2019 www.talkhealthpartnership.com Pioneering medical device Pelviva, treating bladder leakage...
Pioneering medical device Pelviva, treating bladder leakage in women – the single largest condition in female health has teamed up with talkhealth, Bladder & Bowel UK, ERIC, The Urology Foundation and Wellbeing for...
The most common oncologic outcome following radical prostatectomy (RP) for localised prostate cancer is achieving undetectable prostate-specific antigen (PSA) levels (<0.1 ng/ml), indicating an absence of detectable disease. However, the landscape of RP is shifting as active surveillance becomes the...
Nurses can help support change in prostate cancer care by understanding change management and models and provide leadership in improving prostate cancer care. An important part of being able to lead change is to understand change theories such as the...
In the UK, due to cancer reorientation programmes by the NHS, radical cystectomies happen only in regional cancer centres. But there is no reason why simple cystectomies cannot take place in district general hospitals, often much closer to patients and...
The functional side-effects of both radical prostatectomy and radiotherapy for prostate cancer are well known. The aim of this study was to evaluate if there was a significant worsening in recovery of urinary continence in those undergoing radical prostatectomy followed...